GENERIC NAME | This data is not available for free |
INDICATION'S | Neurology>ADHD>Treat. |
MARKETER'S COUNTRY | USA |
OBSERVATION'S | Approved Strengths: 20, 30, 40, 50, 60 & 70 mg |
STATUS | FDA Approved. USA Patent Expiration: 06.01.2024 |
UPDATE | 01.03.08 |
COMPANY | This data is not available for free |
PATENT NUMBER | This data is not available for free |
Want more information ? Interested in the hidden information ? Click here and do your request. |